You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
HIV cure research: Advances and prospects
|
|---|---|
| Published in |
Virology, March 2014
|
| DOI | 10.1016/j.virol.2014.02.021 |
| Pubmed ID | |
| Authors |
Caroline P. Passaes, Asier Sáez-Cirión |
| Abstract |
Thirty years after the identification of HIV, a cure for HIV infection is still to be achieved. Advances of combined antiretroviral therapy (cART) in recent years have transformed HIV infection into a chronic disease when treatment is available. However, in spite of the favorable outcomes provided by the newer therapies, cART is not curative and patients are at risk of developing HIV-associated disorders. Moreover, universal access to antiretroviral treatment is restricted by financial obstacles. This review discusses the most recent strategies that have been developed in the search for an HIV cure and to improve life quality of people living with HIV. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 17% |
| France | 1 | 17% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 271 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Germany | 2 | <1% |
| Japan | 2 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Portugal | 1 | <1% |
| Netherlands | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 260 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 49 | 18% |
| Student > Master | 48 | 18% |
| Student > Bachelor | 45 | 17% |
| Researcher | 41 | 15% |
| Student > Doctoral Student | 15 | 6% |
| Other | 34 | 13% |
| Unknown | 39 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 68 | 25% |
| Medicine and Dentistry | 49 | 18% |
| Biochemistry, Genetics and Molecular Biology | 31 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 7% |
| Immunology and Microbiology | 20 | 7% |
| Other | 37 | 14% |
| Unknown | 46 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2021.
All research outputs
#1,387,841
of 25,374,647 outputs
Outputs from Virology
#143
of 9,498 outputs
Outputs of similar age
#13,626
of 235,206 outputs
Outputs of similar age from Virology
#2
of 41 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,498 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,206 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.